The latest biotech news - Labiotech.eu

Home News and Trends Page 91

Latest Posts

intellidigest

News and Trends 27 Sep 2022

Watch: IntelliDigest using biotech to tackle food waste

After obtaining a PhD in environmental engineering, Ifeyinwa Kanu set up IntelliDigest in 2016. Based in Edinburgh, Scotland, at the Heriot-Watt University Business School Incubator, the biotechnology company specializes in food sustainability. The company aims to address the sustainability challenges faced by the entire global food system, including producers, processors, manufacturers, retailers, and consumers. This […]

September 27, 2022 - 2 minutesmins - By Jim Cornall

shutterstock foodtech

News and Trends 27 Sep 2022

Capagro launches second fund of €200M to support promising European startups

The most promising startups in the European FoodTech and AgTech sectors will be supported by funding from Capagro. The European AgriTech is building on the success of its first fund five years ago and is now launching its second with a fund of €200 million ($193 million). The launch of the new fund, Capagro Agri-Food […]

September 27, 2022 - 4 minutesmins - By Liza Laws

cancer immunotherapy

News and Trends 27 Sep 2022

Angel Pharma announces approval of IND application for clinical trial of mupadolimab

Approval of an investigational new drug (IND) application for mupadolimab has been granted by the Center for Drug Evaluation (CDE) to initiate a phase 1/1b clinical trial in China. Angel Pharma, a clinical stage biopharmaceutical company owns the rights to mupadolimab in Greater China. Mupadolimab is a humanized monoclonal antibody directed against CD73. In preclinical […]

September 27, 2022 - 2 minutesmins - By Liza Laws

shutterstock ischemic stroke

News and Trends 26 Sep 2022

Acticor Biotech enrolls first U.S. patient in study for people with acute ischemic stroke

The first U.S. patient was enrolled in a study evaluating glenzocimab in those with acute ischemic stroke. Acticor Biotech, a clinical stage biotech company, made the announcement today (September 26). The patient was enrolled at the CHI Memorial Stroke and Neuroscience Center, Chattanooga, Tennessee, by neurologist, Ruchir Shah. Significant potential He said: “I am very […]

September 26, 2022 - 3 minutesmins - By Liza Laws

CEO and founder Bjorn Manuel Hegelich aligning laser beams within a laser system at TAU's facility in Austin, Texas.

News and Trends 26 Sep 2022

TAU Systems to build new generation of compact particle accelerators after $15M investment

TAU Systems has raised $15 million in seed investment to bring particle accelerators to a multitude of users by harnessing the latest laser technology to make electrons surf on three-dimensional plasma waves and accelerate them to ultra-high energies. The news is significant as, until now, high-energy particle accelerators have been limited to countries and governmental […]

September 26, 2022 - 2 minutesmins - By Jim Cornall

non-small cell lung cancer NSCLC

News and Trends 26 Sep 2022

TILT and MSD working on immunotherapy trial for non-small cell lung cancer

TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, has signed a second clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA, for a new clinical trial evaluating TILT-123, its oncolytic adenovirus armed with two human cytokines, in combination with KEYTRUDA (pembrolizumab), MSD’s anti-PD-1 therapy. The […]

September 26, 2022 - 3 minutesmins - By Jim Cornall

ADVERTISEMENT

monkeypox

News and Trends 26 Sep 2022

Commercial launch of monkeypox PCR test for research use in laboratories worldwide

A newly developed molecular polymerase chain reaction (PCR) test for monkeypox is now commercially available globally for research use only applications. Becton, Dickinson and Company (BD) and CerTest Biotec made the announcement today (September 26) that the test can be used in laboratories. The teams leveraged the BD MAX System open architecture reagent suite to develop […]

September 26, 2022 - 3 minutesmins - By Liza Laws

labatory

News and Trends 26 Sep 2022

Australian Agilex Biolabs expands its capacity with new toxicology testing facility

A toxicology facility with more than 10,000 sq ft of laboratory space has opened in Australia and will help Agilex Biolabs expand its capacity to serve the biotech, pharma and animal health industries. After more than 25 years in the industry, Agilex Biolabs says it will now be able to share with an even more […]

September 26, 2022 - 2 minutesmins - By Liza Laws

Cleara Biotech closes $2.5M round for senescence treatment

News and Trends 26 Sep 2022

Surge raises $2.6M in funding for technology and secures exclusive licensing agreement

Surge, a biotech and artificial intelligence innovator that produces technology to decode immune fingerprints, has received $2.6 million in funding. The technology accurately identifies patients at risk before surgery and enables physicians to quickly forecast the risk of postoperative complications. The funding round was co-led by HCVC, a global early-stage fund dedicated to high-potential […]

September 26, 2022 - 4 minutesmins - By Liza Laws

funding

News and Trends 26 Sep 2022

Kupando raises €13M in series A funding round led by Remiges Ventures

A company developing agonists that stimulate immune cells today (September 26) announced it has secured €13 million ($12.6 million) in series A funding. Germany-based Kupando develops TLR/47 that stimulate innate immunity for use in oncology and infectious diseases. Kupando says it will use the funds to complete IND-enabling work and to initiate the clinical development […]

September 26, 2022 - 2 minutesmins - By Liza Laws

month ulcer aphthous stomatitis

News and Trends 26 Sep 2022

Mucocort signs deal for pain-relieving mouth ulcer treatment

Mucocort AB is a Swedish company that has developed a unique self-absorbing pain relief patch for people suffering from recurrent mouth ulcers – aphthous stomatitis. The company has signed a production agreement with medical technology company Aurena Laboratories AB, which also becomes a stakeholder in Mucocort. Aphthous stomatitis is a common disorder. Sixty percent of […]

September 26, 2022 - 4 minutesmins - By Jim Cornall

Cuba

News and Trends 26 Sep 2022

Cuba to receive €46.7M to boost biopharma sector

The Central American Bank for Economic Integration (CABEI) has signed the first financing agreement with the Republic of Cuba for the execution of a project to strengthen the Cuban biopharmaceutical industry. On of the goals of the project is to combat COVID-19. The funding is for a total of €46.7 million ($45 million). The initiative, […]

September 26, 2022 - 2 minutesmins - By Jim Cornall

ADVERTISEMENT